Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls.

"appendix a supplementary material the following are the supplementary data to this article: supplementary data 1 acknowledgement addressing the cumulative risk from emerging biological chemical and social threats that will exacerbate the second outbreak of covid-19 of ceepac/uaslp 2020."

"Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Omar Ornelas Rebolledo who is director of the company LABINNOVA which financed the study and the Cyranose 320 equipment."

"Maribel Rodríguez-Aguilar: Conceptualization, Analytical methods, writing. Lorena Díaz de León-Martínez: Conceptualization and Analytical methods, Writing and Editing. Blanca Nohemí Zamora-Mendoza: Conceptualization, Sampling. Andreu Comas-García: Supervision and validation. Sandra Elizabeth Guerra Palomares: Molecular testing of samples. Christian Alberto García-Sepúlveda: Sampling, biosafety supervision; Luz Eugenia Alcántara-Quintana: Sampling and Supervision. Fernando Díaz-Barriga: Conceptualization, Supervision, review and editing; Rogelio Flores-Ramírez: Conceptualization, Analytical methods, Writings, Editing and Funding."